Troleandomycin


Generic Medicine Info
Administration
Should be taken on an empty stomach (i.e. At least one hour before food or two hours after food).
Contraindications
Hypersensitivity. Patients who previously developed liver disorders while receiving the drug.
Special Precautions
Hepatic or renal impairment; predisposition to prolongation of QT interval; history of arrhythmias. Monitor LFT if used for >14 days or repeated courses used.
Adverse Reactions
GI disturbances; hypersensitivity reactions.
Potentially Fatal: Stevens-Johnson syndrome; toxic epidermal necrolysis; hepatotoxicity; arrhythmias.
Drug Interactions
Increased plasma concentrations of calcium channel blockers, bromocriptine, aprepitant, opioids, carbamazepine, etoposide, warfarin, aminophylline, theophylline, carbamazepine, ciclosporin, methylprednisolone, toremifene, benzodiazepines and tacrolimus. Increased risk of hepatotoxicity with rifampicin. Increased risk of ergotism with ergot alkaloids.
CIMS Class
Macrolides
ATC Classification
J01FA08 - troleandomycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections.
Disclaimer: This information is independently developed by CIMS based on troleandomycin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in